Circulating Tumor Cell Detection in Lung Cancer: But to What End?
The understanding of the natural history and biology of lung cancer has been enhanced by studies into circulating tumor cells (CTCs). Fundamental and translational research, as well as clinical trials in the characterization and behavior of these cells, have constantly contributed to improving under...
Main Authors: | Véronique Hofman, Simon Heeke, Charles-Hugo Marquette, Marius Ilié, Paul Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/262 |
Similar Items
-
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
by: Simon Heeke, et al.
Published: (2021-04-01) -
Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment
by: Simon Heeke, et al.
Published: (2019-07-01) -
Clinical utility of circulating tumor cells: an update
by: Antoine Vasseur, et al.
Published: (2021-06-01) -
ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients
by: Paul Hofman
Published: (2017-08-01) -
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
by: Joanna Kapeleris, et al.
Published: (2018-08-01)